Skip to main content
Back to feed
HealthReportedMediumDeveloping
5.0

Informal market now supplies majority of GLP-1 doses in Brazil

A Scanntech study estimates that 53.8% of GLP-1 doses consumed in Brazil in H1 2026 came from informal channels, surpassing formal pharmacy sales for the first time. This signals a significant shift in drug distribution, raising concerns about quality control and regulatory oversight. The trend reflects high demand and potential access barriers in the formal market.

Valor Econômico1 day agoBRCredibility 41%View source

Score Breakdown

Mosaic Score5.0
Model confidence0.5
Significance0.5
Source credibility0.4

Intelligence Tags

#glp-1#brazil#pharmaceuticals#informal-market#drug-distribution

Entities

country
Source

Related signals

8 found